Jump to content

Anil Suri: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
AnomieBOT (talk | contribs)
Bots
6,435,054 edits
m Dating maintenance tags: {{Dead link}}
m Reverted edits by Khammarmin (talk) (HG) (3.4.10)
(13 intermediate revisions by 13 users not shown)
Line 5: Line 5:
}}
}}


'''Anil Suri''' is a cancer researcher working in the field of Translational [[Cancer research]] at the National Institute of Immunology in [[New Delhi]], [[India]].<ref>{{Cite web|url=http://www.nii.res.in/research/faculty|title = Faculty &#124; National Institute of Immunology}}</ref><ref name=anilksuri >{{Cite web|url=http://www.nii.res.in/research/anil-k-suri|title=Anil K. Suri &#124; National Institute of Immunology}}</ref> He is a fellow of the Indian [[National Academy of Medical Sciences]],<ref name="nams2013">{{cite web |url=http://nams-india.in/docs_pdfs/fellow2013.pdf |title=List of Fellows: October 2013 |access-date= 5 August 2023}}</ref> a fellow of [[National Academy of Sciences, India]],<ref name=nasi2009>{{Cite web|url=http://www.nasi.nic.in/fellows.asp?RsFilter=S|title=The National Academy of Sciences, India - Fellows}}</ref> editorial board member of [[Cancer Research (journal)|Cancer Research]],<ref>{{Cite web|url=http://cancerres.aacrjournals.org/site/misc/edboard.xhtml|title=Editorial Board &#124; Cancer Research}}</ref> vice president of the Indian Society for the Study of Reproduction and Fertility (ISSRF)<ref name="vicepresidentissrf">{{cite web |url=http://www.issrf.org/ |title=Home |website=issrf.org}}</ref> and was an Executive Member of Indian Association of Cancer Research. <ref name=iacr2016>{{Cite web |url=http://www.iacr.org.in/ |title=Indian Association for Cancer Research - Home Page |access-date=2022-02-22 |archive-date=2020-08-12 |archive-url=https://web.archive.org/web/20200812084900/http://iacr.org.in/ |url-status=dead }}</ref>
'''Anil Suri''' is a cancer researcher working in the field of Translational [[Cancer research]] at the National Institute of Immunology in [[New Delhi]], [[India]].<ref>{{Cite web|url=http://www.nii.res.in/research/faculty|title = Faculty &#124; National Institute of Immunology}}</ref><ref name=anilksuri >{{Cite web|url=http://www.nii.res.in/research/anil-k-suri|title=Anil K. Suri &#124; National Institute of Immunology}}</ref> He is a fellow of the Indian [[National Academy of Medical Sciences]],<ref name="nams2013">{{cite web |url=http://nams-india.in/docs_pdfs/fellow2013.pdf |title=List of Fellows: October 2013 |access-date= 5 August 2023}}</ref> editorial board member of [[Cancer Research (journal)|Cancer Research]],<ref>{{Cite web|url=http://cancerres.aacrjournals.org/site/misc/edboard.xhtml|title=Editorial Board &#124; Cancer Research}}</ref> vice president of the Indian Society for the Study of Reproduction and Fertility (ISSRF),<ref name="vicepresidentissrf">{{cite web |url=http://www.issrf.org/ |title=Home |website=issrf.org}}</ref> and was an Executive Member of Indian Association of Cancer Research. <ref name=iacr2016>{{Cite web |url=http://www.iacr.org.in/ |title=Indian Association for Cancer Research - Home Page |access-date=2022-02-22 |archive-date=2020-08-12 |archive-url=https://web.archive.org/web/20200812084900/http://iacr.org.in/ |url-status=dead }}</ref>


Suri has been a visiting professor at [[Mount Sinai Medical Center]], [[Memorial Sloan-Kettering Cancer Center]], [[Weill Cornell Medical College]], [[National Cancer Institute]], Lombardi Comprehensive Cancer Centre at the [[Georgetown University Medical Center]] and [[Queen's University Belfast]].<ref name=anilksuri/>
Suri has been a visiting professor at [[Mount Sinai Medical Center]], [[Memorial Sloan-Kettering Cancer Center]], [[Weill Cornell Medical College]], [[National Cancer Institute]], Lombardi Comprehensive Cancer Centre at the [[Georgetown University Medical Center]], and [[Queen's University Belfast|Queen's University, Belfast]].<ref name=anilksuri/>


==Cancer research==
==Cancer research==
Suri discovered [[SPAG9]], a novel cancer antigen that is expressed in the reproductive tract, breasts, and various other malignancies.<ref name=anilksuri/> Human clinical trials employing recombinant [[SPAG9]] have been initiated in [[Cervical Cancer|cervical cancer]] patients using [[Dendritic Cell|dendritic cell]]-based [[vaccine]] at [[Adyar Cancer Institute]] (WIA), Chennai (“[[Cancer immunotherapy]] [[dendritic cell]] [[vaccine]] based [[immunotherapy]] in [[cervical cancer]]-A phase II, double blind, randomized, three arm study to evaluate the efficacy of [[dendritic cell]] [[vaccine]] in stage IIIB [[cervical cancer]]” (n=54 patients)” Protocol No. CI/MOL ONC/DC VACCINE Version 5.0).<ref name=cancerresearchprogramme>http://www.nii.res.in/pdf/cancer-research-programme.pdf {{Bare URL PDF|date=March 2022}}{{dead link|date=August 2023}}</ref>
Suri discovered [[SPAG9]], a novel cancer antigen that is expressed in the reproductive tract, breasts, and various other malignancies.<ref name=anilksuri/> Human clinical trials employing recombinant [[SPAG9]] have been initiated in [[Cervical Cancer|cervical cancer]] patients using [[Dendritic Cell|dendritic cell]]-based [[vaccine]] at [[Adyar Cancer Institute]] (WIA), Chennai (“[[Cancer immunotherapy]] [[dendritic cell]] [[vaccine]] based [[immunotherapy]] in [[cervical cancer]]-A phase II, double blind, randomized, three arm study to evaluate the efficacy of [[dendritic cell]] [[vaccine]] in stage IIIB [[cervical cancer]]” (n=54 patients)” Protocol No. CI/MOL ONC/DC VACCINE Version 5.0).<ref name=cancerresearchprogramme>{{cite web |title=Translating basic research to clinical cancer research for cervical cancer treatment |url=http://www.nii.res.in/pdf/cancer-research-programme.pdf |archive-url=https://web.archive.org/web/20160509091628/http://www.nii.res.in/pdf/cancer-research-programme.pdf |archive-date=9 May 2016 |url-status=dead}}</ref>


He has one patents in India, the United States, Europe, Australia and Singapore, mostly related to siRNA and methods to diagnose cancer using antibodies and antigens.<ref>{{Cite web |title=Indian Patents. 257434:"siRNA USEFUL IN INHIBITING CELLULAR GROWTH/PROLIFERATION OF CANCEROUS TISSUES" |url=http://www.allindianpatents.com/patents/257434-sirna-useful-in-inhibiting-cellular-growth-proliferation-of-cancerous-tissues}}</ref><ref>{{Cite web |title=Nucleotide sequences |url=http://www.google.com.na/patents/US8227591}}</ref><ref name="cancerresearchprogramme" /><ref name="researchip">{{Cite web |title=IP &#124; National Institute of Immunology |url=http://www.nii.res.in/research/ip}}</ref><ref>{{Cite web |date=9 March 2013 |title=Intellectual Property Office - Patent document and information service (Ipsum) |url=https://www.ipo.gov.uk/p-ipsum/Case/PublicationNumber/EP1796723}}</ref><ref>{{Cite web |title=Novel cancer associated antibodies and their use in cancer diagnosis |url=http://www.google.co.in/patents/US20100221742}}</ref><ref>{{Cite web |title=Novel cancer associated antibodies and antigens and their use in cancer diagnosis by National Institute of Immunology – AU 2005290997 |url=http://www.ipaustralia.com.au/applicant/national-institute-of-immunology/patents/AU2005290997/}}</ref><ref>{{Cite web |title=Inhibition of SPAG9 expression with siRNAs by National Institute of Immunology - Patent No. 2006219666 |url=http://www.ipmonitor.com.au/patents/case/2006219666}}</ref>
He holds patents in India, the United States of America, Europe, Australia and Singapore, primarily related to siRNA and methods used to diagnose cancer using antibodies and antigens.<ref>{{Cite web |title=Indian Patents. 257434:"siRNA USEFUL IN INHIBITING CELLULAR GROWTH/PROLIFERATION OF CANCEROUS TISSUES" |url=http://www.allindianpatents.com/patents/257434-sirna-useful-in-inhibiting-cellular-growth-proliferation-of-cancerous-tissues}}</ref><ref>{{Cite web |title=Nucleotide sequences |url=http://www.google.com.na/patents/US8227591}}</ref><ref name="cancerresearchprogramme" /><ref name="researchip">{{Cite web |title=IP &#124; National Institute of Immunology |url=http://www.nii.res.in/research/ip}}</ref><ref>{{Cite web |date=9 March 2013 |title=Intellectual Property Office - Patent document and information service (Ipsum) |url=https://www.ipo.gov.uk/p-ipsum/Case/PublicationNumber/EP1796723}}</ref><ref>{{Cite web |title=Novel cancer associated antibodies and their use in cancer diagnosis |url=http://www.google.co.in/patents/US20100221742}}</ref><ref>{{Cite web |title=Novel cancer associated antibodies and antigens and their use in cancer diagnosis by National Institute of Immunology – AU 2005290997 |url=http://www.ipaustralia.com.au/applicant/national-institute-of-immunology/patents/AU2005290997/}}</ref><ref>{{Cite web |title=Inhibition of SPAG9 expression with siRNAs by National Institute of Immunology - Patent No. 2006219666 |url=http://www.ipmonitor.com.au/patents/case/2006219666}}</ref>


He is involved in a cancer research program that aims to identify leads for early detection and diagnosis, treatments and cure. This involves [[biomarker]] discovery for early detection and diagnosis and [[Cancer Immunotherapy|cancer immunotherapy]]. The cancer biomarker candidates discovered by Dr. Suri in various cancers (including breast, ovarian, cervical, renal cell carcinoma, thyroid, bladder, colon and leukemia) have been published in prestigious international cancer journals.
He is involved in a cancer research program that aims to identify leads for early detection and diagnosis, treatments and cure. This involves [[biomarker]] discovery for early detection, diagnosis, and [[Cancer Immunotherapy|cancer immunotherapy]]. The cancer biomarker candidates identified by Dr. Suri across various cancers (such as breast, ovarian, cervical, renal cell carcinoma, thyroid, bladder, colon, and leukemia) have been published in renowned international cancer journals.


==Awards==
==Awards==
Suri has received three awards from the ISSRF,<ref name="anilksuri" /><ref>{{Cite web |url=http://www.issrf.org/announcements/founder-president-dr-t-c-anand-kumar-memorial-oration |title=Founder-President Dr. T. C. Anand Kumar Memorial Oration - Indian Society for the Study of Reproduction & Fertility |access-date=2016-08-21 |archive-date=2016-09-18 |archive-url=https://web.archive.org/web/20160918141103/http://www.issrf.org/announcements/founder-president-dr-t-c-anand-kumar-memorial-oration |url-status=dead }}</ref><ref>{{Cite web |url=http://www.issrf.org/announcements/lsramaswami_memorial_oration |title=Prof. L. S. Ramaswami Memorial Oration - Indian Society for the Study of Reproduction & Fertility |access-date=2016-08-21 |archive-date=2016-09-18 |archive-url=https://web.archive.org/web/20160918122434/http://www.issrf.org/announcements/lsramaswami_memorial_oration |url-status=dead }}</ref><ref>{{Cite web |url=http://www.issrf.org/announcements/labhsetwar-award |title=Labhsetwar Award - Indian Society for the Study of Reproduction & Fertility |access-date=2016-08-21 |archive-date=2016-09-18 |archive-url=https://web.archive.org/web/20160918122418/http://www.issrf.org/announcements/labhsetwar-award |url-status=dead }}</ref> the [[Post Graduate Institute of Medical Education and Research]],<ref name="anilksuri" /> two awards from the [[Department of Biotechnology|Indian Department of Biotechnology]]{{Citation needed|date=January 2023}}, the [[National Academy of Medical Sciences]],<ref name="nams2013" /> and [[National Academy of Sciences]].<ref name="nasi2009" />
Suri has received three awards from the ISSRF,<ref name="anilksuri" /><ref>{{Cite web |url=http://www.issrf.org/announcements/founder-president-dr-t-c-anand-kumar-memorial-oration |title=Founder-President Dr. T. C. Anand Kumar Memorial Oration - Indian Society for the Study of Reproduction & Fertility |access-date=2016-08-21 |archive-date=2016-09-18 |archive-url=https://web.archive.org/web/20160918141103/http://www.issrf.org/announcements/founder-president-dr-t-c-anand-kumar-memorial-oration |url-status=dead }}</ref><ref>{{Cite web |url=http://www.issrf.org/announcements/lsramaswami_memorial_oration |title=Prof. L. S. Ramaswami Memorial Oration - Indian Society for the Study of Reproduction & Fertility |access-date=2016-08-21 |archive-date=2016-09-18 |archive-url=https://web.archive.org/web/20160918122434/http://www.issrf.org/announcements/lsramaswami_memorial_oration |url-status=dead }}</ref><ref>{{Cite web |url=http://www.issrf.org/announcements/labhsetwar-award |title=Labhsetwar Award - Indian Society for the Study of Reproduction & Fertility |access-date=2016-08-21 |archive-date=2016-09-18 |archive-url=https://web.archive.org/web/20160918122418/http://www.issrf.org/announcements/labhsetwar-award |url-status=dead }}</ref> the [[Post Graduate Institute of Medical Education and Research]],<ref name="anilksuri" /> two awards from the [[Department of Biotechnology|Indian Department of Biotechnology]]{{Citation needed|date=January 2023}}, one from the [[National Academy of Medical Sciences]],<ref name="nams2013" /> and one from the [[National Academy of Sciences]].<ref name="nasi2009">{{Cite web |title=The National Academy of Sciences, India - Fellows |url=http://www.nasi.nic.in/fellows.asp?RsFilter=S}}</ref>


==Selected Publications==
==Selected publications==
===Cervical cancer===
===Cervical cancer===
*Small interfering RNA-mediated down regulation of Sperm-Associated Antigen 9 inhibits cervix tumor growth. Garg M, Kanojia D, Suri S, and Suri A. [[Cancer (journal)]]. 2009. {{PMID|19813278}}
*Small interfering RNA-mediated down regulation of Sperm-Associated Antigen 9 inhibits cervix tumor growth. Garg M, Kanojia D, Suri S, and Suri A. [[Cancer (journal)]]. 2009. {{PMID|19813278}}
Line 60: Line 60:
[[Category:Cancer researchers]]
[[Category:Cancer researchers]]
[[Category:Fellows of the National Academy of Medical Sciences]]
[[Category:Fellows of the National Academy of Medical Sciences]]
[[Category:Fellows of The National Academy of Sciences, India]]
[[Category:Fellows of the National Academy of Sciences, India]]
[[Category:Year of birth missing (living people)]]
[[Category:Year of birth missing (living people)]]

Revision as of 21:51, 5 August 2024

Anil Suri is a cancer researcher working in the field of Translational Cancer research at the National Institute of Immunology in New Delhi, India.[1][2] He is a fellow of the Indian National Academy of Medical Sciences,[3] editorial board member of Cancer Research,[4] vice president of the Indian Society for the Study of Reproduction and Fertility (ISSRF),[5] and was an Executive Member of Indian Association of Cancer Research. [6]

Suri has been a visiting professor at Mount Sinai Medical Center, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, National Cancer Institute, Lombardi Comprehensive Cancer Centre at the Georgetown University Medical Center, and Queen's University, Belfast.[2]

Cancer research

Suri discovered SPAG9, a novel cancer antigen that is expressed in the reproductive tract, breasts, and various other malignancies.[2] Human clinical trials employing recombinant SPAG9 have been initiated in cervical cancer patients using dendritic cell-based vaccine at Adyar Cancer Institute (WIA), Chennai (“Cancer immunotherapy dendritic cell vaccine based immunotherapy in cervical cancer-A phase II, double blind, randomized, three arm study to evaluate the efficacy of dendritic cell vaccine in stage IIIB cervical cancer” (n=54 patients)” Protocol No. CI/MOL ONC/DC VACCINE Version 5.0).[7]

He holds patents in India, the United States of America, Europe, Australia and Singapore, primarily related to siRNA and methods used to diagnose cancer using antibodies and antigens.[8][9][7][10][11][12][13][14]

He is involved in a cancer research program that aims to identify leads for early detection and diagnosis, treatments and cure. This involves biomarker discovery for early detection, diagnosis, and cancer immunotherapy. The cancer biomarker candidates identified by Dr. Suri across various cancers (such as breast, ovarian, cervical, renal cell carcinoma, thyroid, bladder, colon, and leukemia) have been published in renowned international cancer journals.

Awards

Suri has received three awards from the ISSRF,[2][15][16][17] the Post Graduate Institute of Medical Education and Research,[2] two awards from the Indian Department of Biotechnology[citation needed], one from the National Academy of Medical Sciences,[3] and one from the National Academy of Sciences.[18]

Selected publications

Cervical cancer

  • Small interfering RNA-mediated down regulation of Sperm-Associated Antigen 9 inhibits cervix tumor growth. Garg M, Kanojia D, Suri S, and Suri A. Cancer (journal). 2009. PMID 19813278
  • Sperm-Associated Antigen 9 (SPAG9) is a biomarker for early cervical carcinoma. Garg M, Kanojia D, Salhan S, Suri S, Gupta A, Lohiya NK, and Suri A. Cancer (journal). 2009. PMID 19326449
  • Germ cell specific Heat shock protein 70-2 is expressed in cervical carcinoma and is involved in growth, migration and invasion of cervix cells. Garg M, D. Kanojia D, S. Saini S, S. Suri S, A. Gupta A, A. Surolia A, and A. Suri A. Cancer (journal). 2010. PMID 20564126
  • Gene silencing of A-kinase anchor protein 4 inhibits cervical cancer growth in vitro and in vivo. Saini S, Agarwal S, Sinha A, Verma A, Parashar D, Gupta N, Ansari AS, Lohiya NK, Jagadish N, Suri A. Cancer Gene Ther. 2013. PMID 23764900

Breast cancer

Ovarian cancer

  • Sperm Associated Antigen 9 (SPAG9), a novel Cancer testis antigen is potential target for Immunotherapy in epithelial ovarian cancer. Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, Gupta A and Suri A. Clinical Cancer Research. 2007. PMID 17332284
  • A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a putative target for immunotherapy of ovarian serous carcinoma. Agarwal S, Saini S, Parashar D, Verma A, Sinha A, Jagadish N, Gupta A, Batra A, Suri S, Bhatnagar A, Ansari AS, Lohiya NK and Suri A. Oncoimmunology. 2013. PMID 23762804

Renal cell carcinoma

  • Sperm Associated Antigen 9 is associated with tumor growth, migration and invasion in Renal cell carcinoma. Garg M, Kanojia D, Khosla A, Dudha N, Sati S, Chaurasiya D, Jagadish N, Seth A, Kumar R, Gupta S, Gupta A, K. Lohiya NK and Suri A. Cancer Research (journal) 2008. PMID 18922895

Colorectal carcinoma

Salivary gland cancer

  • Sperm Associated Antigen 9 (SPAG9) expressions and humoral response in benign and malignant salivary gland tumors. Agarwal S, Parashar D, Gupta N, Jagadish N, Thakar A, Suri V, Kumar R, Gupta A, Ansari AS, Lohiya NK, and Suri A. Oncoimmunology, 2014. PMID 25941602

Thyroid cancer

Chronic myeloid leukemia

References

  1. ^ "Faculty | National Institute of Immunology".
  2. ^ a b c d e "Anil K. Suri | National Institute of Immunology".
  3. ^ a b "List of Fellows: October 2013" (PDF). Retrieved 5 August 2023.
  4. ^ "Editorial Board | Cancer Research".
  5. ^ "Home". issrf.org.
  6. ^ "Indian Association for Cancer Research - Home Page". Archived from the original on 2020-08-12. Retrieved 2022-02-22.
  7. ^ a b "Translating basic research to clinical cancer research for cervical cancer treatment" (PDF). Archived from the original (PDF) on 9 May 2016.
  8. ^ "Indian Patents. 257434:"siRNA USEFUL IN INHIBITING CELLULAR GROWTH/PROLIFERATION OF CANCEROUS TISSUES"".
  9. ^ "Nucleotide sequences".
  10. ^ "IP | National Institute of Immunology".
  11. ^ "Intellectual Property Office - Patent document and information service (Ipsum)". 9 March 2013.
  12. ^ "Novel cancer associated antibodies and their use in cancer diagnosis".
  13. ^ "Novel cancer associated antibodies and antigens and their use in cancer diagnosis by National Institute of Immunology – AU 2005290997".
  14. ^ "Inhibition of SPAG9 expression with siRNAs by National Institute of Immunology - Patent No. 2006219666".
  15. ^ "Founder-President Dr. T. C. Anand Kumar Memorial Oration - Indian Society for the Study of Reproduction & Fertility". Archived from the original on 2016-09-18. Retrieved 2016-08-21.
  16. ^ "Prof. L. S. Ramaswami Memorial Oration - Indian Society for the Study of Reproduction & Fertility". Archived from the original on 2016-09-18. Retrieved 2016-08-21.
  17. ^ "Labhsetwar Award - Indian Society for the Study of Reproduction & Fertility". Archived from the original on 2016-09-18. Retrieved 2016-08-21.
  18. ^ "The National Academy of Sciences, India - Fellows".
Retrieved from "https://en.wikipedia.org/w/index.php?title=Anil_Suri&oldid=1238827066"